The impact of biological interventions for ulcerative colitis on health‐related quality of life

Overview of attention for article published in Cochrane database of systematic reviews, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 2 policy sources

twitter: 3 X users

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 222 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,475 followers.

RT @HeoroCom: #Review: #infliximab, #vedolizumab improve #SF36, #EQ5D #QOL in #UlcerativeColitis; #adalimumab, #golimumab unclear https://t…

Reply Repost Favourite

#Review: #infliximab, #vedolizumab improve #SF36, #EQ5D #QOL in #UlcerativeColitis; #adalimumab, #golimumab unclear https://t.co/AitwFcAJcP

Reply Repost Favourite

RS impacto de terapia biológica sobre mejora de calidad de vida en colitis ulcerosa. Mejor información infliximab. http://t.co/ivNBRO9wu4

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.